Association of Habitual Intake of Probiotic Supplements and Yogurt with Characteristics of the Gut Microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Weiwen ChaiGertraud MaskarinecUnhee LimCarol J BousheyLynne R WilkensV Wendy SetiawanLoïc Le MarchandTimothy W RandolphIsaac C JenkinsJohanna W LampeMeredith A J HullarPublished in: Gut microbiome (Cambridge, England) (2023)
Consumption of probiotics and/or yogurt could be a solution for restoring the balance of the gut microbiota. This study examined associations of regular intake of probiotic supplements or yogurt with the gut microbiota among a diverse population of older adults (N=1,861; 60-72 years). Fecal microbial composition was obtained from 16S rRNA gene sequencing (V1-V3 region). General Linear Models were used to estimate the associations of probiotic supplement or yogurt intake with microbiome measures adjusting for covariates. Compared to non-yogurt consumers (N=1,023), regular yogurt consumers (≥once/week, N=818) had greater Streptococcus (β=0.29, P =0.0003) and lower Odoribacter (β=-0.33, P <0.0001) abundance. The directions of the above associations were consistent across the five ethnic groups but stronger among Japanese Americans ( Streptococcus: β=0.56, P =0.0009; Odoribacter: β=-0.62, P =0.0005). Regular intake of probiotic supplements (N=175) was not associated with microbial characteristics (i.e., alpha diversity and the abundance of 152 bacteria genera). Streptococcus is one of the predominant bacteria genera in yogurt products, which may explain the positive association between yogurt consumption and Streptococcus abundance. Our analyses suggest that changes in Odoribacter were independent of changes in Streptococcus abundance. Future studies may investigate whether these microbial genera and their sub-level species mediate potential pathways between yogurt consumption and health.
Keyphrases
- biofilm formation
- candida albicans
- microbial community
- antibiotic resistance genes
- healthcare
- weight gain
- randomized controlled trial
- bacillus subtilis
- type diabetes
- escherichia coli
- insulin resistance
- gene expression
- clinical trial
- single cell
- genome wide
- wastewater treatment
- metabolic syndrome
- current status
- dna methylation
- pseudomonas aeruginosa
- lactic acid
- climate change
- risk assessment